Antelope Surgical Solutions and SHINE Announce Partnership to Advance Clinical Radiopharmaceutical Development

Antelope Surgical Solutions and SHINE Announce Partnership to Advance Clinical Radiopharmaceutical Development
No items found.

About Antelope Surgical Solutions, Inc.
Headquartered in New York, NY, Antelope Surgical Solutions, Inc. develops groundbreaking multimodal radiopharmaceuticals for imaging, therapy, and fluorescence-guided surgery. The company’s cutting-edge GMP manufacturing facility, equipped with robotic high-throughput synthesis, enables scalable, cost-efficient production of precision radiopharmaceuticals. Antelope also develops code to support fluorescent computer vision, electronic technical document submission, and GMP-compliant manufacturing. Its patented platform integrates PET imaging, therapeutic isotopes, and surgical guidance into single-agent solutions, advancing precision oncology. For more information, visit www.antelopesurgical.com.


About SHINE Technologies
Based in Janesville, Wisconsin, SHINE specializes in the production of n.c.a. Lu-177 and other medical isotopes. Through innovative fusion technology, SHINE is advancing cancer treatment and diagnostics while exploring applications in healthcare and sustainable energy.

Lutetium-177 Information Sheet (EU Distribution)Ilumira Information Sheetdownload PDF RESOURCE HERE